Centre Hospitalier de Mulhouse

Mulhouse 68100

0 studies enrolling now · 6 studies all time

What they study most

Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Follicular Lymphoma (FL), Granulomatosis With Polyangiitis (Wegener's) (GPA), Marginal Zone Lymphoma, Microscopic Polyangiitis (MPA), Non Hodgkin Lymphoma, Non-Small Cell Lung Cancer, PONV

Studies at this site

• Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC — Running, not enrolling
• Zandelisib (ME-401) in Subjects With Follicular Lymphoma or Marginal Zone Lymphoma After Failure of Two or More Prior Therapies (TIDAL) — Stopped early
• A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia — Completed
• Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis — Completed
• Study Evaluating the Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL) (Tugela ) — Completed
• Phase IIIb Study of APD421 in Combination as PONV Prophylaxis — Completed